Skip to main content
SpringerLink
Log in

Prime pick: Researchers get selective about T cells for cancer therapy

  • News Feature
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sommermeyer, D. et al. Leukemia 30, 492–500 (2016).

    Article  CAS  Google Scholar 

  2. Stemberger, C. et al. Immunity 27, 985–997 (2007).

    Article  CAS  Google Scholar 

  3. Gattinoni, L. et al. J. Clin. Invest. 115, 1616–1626 (2005).

    Article  CAS  Google Scholar 

  4. Gattinoni, L. et al. Nat. Med. 17, 1290–1297 (2011).

    Article  CAS  Google Scholar 

  5. Gattinoni, L. et al. Nat. Med. 15, 808–813 (2009).

    Article  CAS  Google Scholar 

  6. Sukumar, M. et al. Cell Metab. 23, 63–76 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shraddha Chakradhar is Nature Medicine's assistant news editor, based in Cambridge, Massachusetts.,

    Shraddha Chakradhar

Authors
  1. Shraddha Chakradhar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chakradhar, S. Prime pick: Researchers get selective about T cells for cancer therapy. Nat Med 22, 456–458 (2016). https://doi.org/10.1038/nm0516-456

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0516-456

  • Springer Nature America, Inc.

Search

Navigation